Position in AUTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,017,330
+$717,616 QoQ
Shares Held
1,260,832
+33.9% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 84 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,796 across 523 Biotechnology names. AUTL ranks #211 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in AUTL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,017,330 | 1,260,832 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,299,714 | 941,823 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $1,054,739 | 462,606 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $479,841 | 309,576 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,299,863 | 553,134 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $6,599,175 | 1,817,955 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $10,108,852 | 2,904,843 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,405,216 | 690,473 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $524,015 | 81,369 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $354,023 | 151,942 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $381,546 | 160,314 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $103,770 | 56,397 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $180,997 | 95,262 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $94,052 | 43,950 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $193,522 | 68,383 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $730,829 | 175,259 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $809,327 | 155,940 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,264,444 | 193,045 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,847,672 | 278,264 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $809,224 | 141,226 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,155,126 | 129,209 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $415,431 | 35,690 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,451,965 | 90,578 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||